Table 1 of Barliya, Mol Vis 2017; 23:922-932.

Table 1. PDR patients’ demographic and clinical characteristics.

Variable Control PDR1 PDR2
Patients n=10 n=7 n=5
Age 68±9 58±11 44±8
Gender (F/M) 5/5 1/6 1/4
Diabetes (yes/no) 2/8 6/0 6/0
Hypertention (yes/no) 5/2 3/4 2/3
Smoking n/a n/a n/a
Operated eye (R/L) 5/5 2/5 3/2
VH (yes/no) 0/10 5/2 4/1
TRD (yes/no) n/a 2/5 1/4
Glaucoma (yes/no) 2/8 2/5 1/4
AMD (yes/no) 1/8 0/7 0/5
Avastin pre-treatment (yes/no) 0/8 5/2 2/3
HBA1C n/a 8.8±1 9.8±3

Control (includes MH, macular holes; ERM, epiretinal membrane); PDR, proliferative diabetic retinopathy; PDR1- with no need for repeated surgical intervention; PDR2- with repeated vitreous bleeding or other complication.

Barliya, Mol Vis 2017; 23:922-932. http://www.molvis.org/molvis/v23/922

©2017 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535